OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19 Susceptibility in chronic obstructive pulmonary disease
Jordi Olloquequi
European Journal of Clinical Investigation (2020) Vol. 50, Iss. 10
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection
Helena C. Maltezou, Vasilios Raftopoulos, Rengina Vorou, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 7, pp. 1132-1138
Open Access | Times Cited: 94

Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease
Sarah de Oliveira Rodrigues, Carolina Medina Coeli da Cunha, Giovanna Martins Valladão Soares, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 979-979
Open Access | Times Cited: 66

Hand sanitizers as a preventive measure in COVID-19 pandemic, its characteristics, and harmful effects: a review
Parixit Prajapati, Heli Desai, Chandni Chandarana
Journal of the Egyptian Public Health Association (2022) Vol. 97, Iss. 1
Open Access | Times Cited: 66

Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools
Hossein Abbaszadeh, Farzaneh Ghorbani, Sanaz Abbaspour‐Aghdam, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 51

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1312-1312
Open Access | Times Cited: 57

Effect of comorbid pulmonary disease on the severity of COVID ‐19: A systematic review and meta‐analysis
Aşkın Gülşen, Inke R. König, Uta Jappe, et al.
Respirology (2021) Vol. 26, Iss. 6, pp. 552-565
Open Access | Times Cited: 43

The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Maryam Golzardi, Altijana Hromić‐Jahjefendić, Jasmin Šutković, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 913-913
Open Access | Times Cited: 6

SARS-CoV-2 Vaccine Development: An Overview and Perspectives
Yi Liu, Kai Wang, Tarik F. Massoud, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 844-858
Open Access | Times Cited: 43

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience
Agata Czarnowska, Waldemar Brola, Olga Zajkowska, et al.
Neurologia i Neurochirurgia Polska (2021) Vol. 55, Iss. 2, pp. 212-222
Open Access | Times Cited: 34

Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 16, pp. 5953-5976
Open Access | Times Cited: 28

Change in exacerbation rate of COPD patients before and after COVID-19 infection
Joon Young Choi, Kyung Joo Kim, Chin Kook Rhee
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020
Amy Board, Sun-Kyung Kim, Joo‐Hyun Park, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109297-109297
Open Access | Times Cited: 16

The Aftermath of COVID-19: Exploring Long-Term Effects on the Organ Systems
Maryam Golzardi, Altijana Hromić‐Jahjefendić, Jasmin Šutković, et al.
(2024)
Open Access | Times Cited: 3

An epigenome‐wide DNA methylation study of patients with COVID‐19
Shengyu Zhou, Jintao Zhang, Jiawei Xu, et al.
Annals of Human Genetics (2021) Vol. 85, Iss. 6, pp. 221-234
Open Access | Times Cited: 22

The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta
Yvette Farrugia, Bernard Paul Spiteri Meilak, Neil Grech, et al.
Pulmonary Medicine (2021) Vol. 2021, pp. 1-7
Open Access | Times Cited: 18

Poor Metabolic Health Increases COVID-19-Related Mortality in the UK Biobank Sample
Filip Morys, Alain Dagher
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 17

SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology
Serigne Fallou Wade, Abou Abdallah Malick Diouara, Babacar Ngom, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 540-540
Open Access | Times Cited: 2

Explainable Deep-Learning-Based Depression Modeling of Elderly Community after COVID-19 Pandemic
Hung Viet Nguyen, Haewon Byeon
Mathematics (2022) Vol. 10, Iss. 23, pp. 4408-4408
Open Access | Times Cited: 10

Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities
Hadi Rajabi, Deniz Mortazavi, Nur Konyalılar, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 9

Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways
Daniel Richard, Pushpanathan Muthuirulan, Jennifer A. Aguiar, et al.
iScience (2022) Vol. 25, Iss. 7, pp. 104614-104614
Open Access | Times Cited: 8

Narrative Analysis of the Impact of COVID-19 on Patients with Chronic Obstructive Pulmonary Disease, Their Caregivers, and Healthcare Professionals in Italy
Eleonora Volpato, Stefano Centanni, Paolo Banfi, et al.
International Journal of COPD (2021) Vol. Volume 16, pp. 2181-2201
Open Access | Times Cited: 11

Clinical and epidemiological characteristics of bronchial asthma and chronic obstructive pulmonary disease incidence in Russia before and during the COVID-19 epidemy
Polina G. Svist, N. V. Torchinsky, С. Н. Авдеев, et al.
Russian Journal of Preventive Medicine (2024) Vol. 27, Iss. 6, pp. 42-42
Closed Access | Times Cited: 1

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing
Muhammad Habibulla Alamin, Md. Matiur Rahaman, Farzana Ferdousi, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304425-e0304425
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top